Barr Pharma To Settle ORTHO TRI-CYCLEN LO Patent Litigation With Ortho Women's Health & Urology - Update
Tuesday, January 22, 2008; Posted: 01:58 PM
(RTTNews) - Tuesday, Barr Pharmaceuticals, Inc. (
BRL |
news |
PowerRating |
PR Ch
arts ), a manufacturer of generic and proprietary pharmaceuticals, said that it is in discussions with Ortho Women's Health & Urology, a division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. to settle the outstanding patent litigation involving Ortho Women's Health & Urology's oral contraceptive product, ORTHO TRI-CYCLEN LO.
The US District Court for the District of New Jersey has postponed the trial date. Either party would not disclose the general terms and status of the anticipated settlement until a definitive agreement is reached.
Barr Pharmaceuticals, Inc. is a global specialty pharmaceutical company that operates in more than 30 countries worldwide and is engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals, biopharmaceuticals and active pharmaceutical ingredients.
The Barr Group of companies markets more than 115 generic and 25 proprietary products in the U.S. and more than 1,200 products globally outside of the US.
BRL is currently trading at $53.97, up 46 cents or 0.86% from its previous closing of $53.51.
For comments and feedback: contact editorial@rttnews.com
Copyright(c) 2008 RealTimeTraders.com, Inc. All Rights Reserved
Morning Coffee with TradingMarkets -- Free Newsletter
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
